Home  |  Contact

UniProtKB/Swiss-Prot P51168: Variant p.Arg563Gln

Amiloride-sensitive sodium channel subunit beta
Gene: SCNN1B
Variant information

Variant position:  563
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  LB/B
The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change:  From Arginine (R) to Glutamine (Q) at position 563 (R563Q, p.Arg563Gln).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from large size and basic (R) to medium size and polar (Q)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  1
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description:  Associated with hypertension in South African Black.
Any additional useful information about the variant.

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  563
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  640
The length of the canonical sequence.

Location on the sequence:   IIIDFVWITIIKLVALAKSL  R QRRAQASYAGPPPTVAELVE
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         IIIDFVWITIIKLVALAKSLRQRRAQASYAGPPPTVAELVE

                              ILIDFVWITIIKLVAFAKSLRQKRAQARYAGPPPTVAELVE

Chimpanzee                    IIIDFVWITIIKLVALAKSLRQRRAQASYAGPPPTVAELVE

Mouse                         IIIDFIWITIIKLVASCKGLRRRRPQAPYTGPPPTVAELVE

Rat                           IIIDFIWITVIKLVASCKGLRRRRPQAPYTGPPPTVAELVE

Bovine                        IIIDFVWITIIKLVALAKSVRQKRAQARYEGPPPTVAELVE

Rabbit                        IIIDFVWITIIKLVALAKGLRQRQAQARYAGPPPTVAELVE

Sheep                         IIIDFVWITIIKLVALAKSVR---------GPPPTVAELVE

Xenopus laevis                IIIDCMWITILKFLAWSRNRRQRRKRPQYSDPPPTVSELVE

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 1 – 640 Amiloride-sensitive sodium channel subunit beta
Topological domain 554 – 640 Cytoplasmic


Literature citations

A new mutation, R563Q, of the beta subunit of the epithelial sodium channel associated with low-renin, low-aldosterone hypertension.
Rayner B.L.; Owen E.P.; King J.A.; Soule S.G.; Vreede H.; Opie L.H.; Marais D.; Davidson J.S.;
J. Hypertens. 21:921-926(2003)
Cited for: VARIANT GLN-563; ASSOCIATION WITH HYPERTENSION;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.